CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
OPERATING ACTIVITIES:
Net (loss) income	$ 3,406	$ (7,950)	$ 60,291
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation	27,823	27,309	24,904
Amortization, including accretion and write-off of deferred financing costs	6,648	5,926	6,579
Deferred income taxes	(511)	(7,953)	5,586
Earnings of equity method investee	(3,658)	(1,536)	(1,578)
Loss (gain) on sale of fixed assets	(165)	185	(98)
Share-based compensation expense	5,960	5,888	6,191
Excess tax benefit related to share-based compensation expense	(563)	(46)	(1,289)
Gain on disposal	(30,718)
Gain on disposal of business, net	(2,942)
Gain on disposal of Non-core Products, net			(33,599)
Property, plant and equipment impairment charge		2,349
Intangible impairment charge	0	0	0
Change in fair value of earn-out contingent consideration	2,065	(3,196)	2,308
Changes in operating assets and liabilities:
Accounts receivable, net	(17,019)	4,164	(1,353)
Inventories, net	(51,270)	4,000	(15,653)
Prepaid expenses and other assets	(5,116)	1,342	(8,898)
Accounts payable	16,515	3,642	(6,980)
Accrued expenses and other liabilities	13,297	(5,483)	(11,906)
Net cash provided by operating activities	(36,248)	28,641	24,505
INVESTING ACTIVITIES:
Capital expenditures, including intangibles	(27,031)	(32,462)	(39,467)
Proceeds from sale of fixed assets	268	127	382
Proceeds from disposal of business, net	1,837		34,386
Proceeds from disposal of joint venture, net	20,999
Proceeds from sale of Canton Facility, net	35,167
Investment in venture capital fund, net	(3,199)	(1,550)	(1,600)
Net cash used for investing activities	28,041	(33,885)	(6,299)
FINANCING ACTIVITIES:
Revolving credit facility borrowings	91,913	71,500	112,000
Revolving credit facility payments	(64,000)	(61,500)	(82,000)
Proceeds from issuance of debt	45,753	41,104	2,208
Repayments of debt	(48,125)	(37,823)	(2,953)
Earn-out consideration cash payment			(3,394)
Common Share repurchase program		(4,995)	(50,000)
Repurchase of Common Shares to satisfy employee tax withholding	(2,665)	(1,773)	(4,119)
Net cash provided by (used for) financing activities	22,876	6,513	(28,258)
Effect of exchange rate changes on cash and cash equivalents	(3,041)	3,247	(1,637)
Net change in cash and cash equivalents	11,628	4,516	(11,689)
Cash and cash equivalents at beginning of period	73,919	69,403	81,092
Cash and cash equivalents at end of period	85,547	73,919	69,403
Supplemental disclosure of cash flow information:
Cash paid for interest	6,055	5,620	4,401
Cash paid for income taxes, net	$ 11,267	(254)	$ 12,222
Supplemental disclosure of non-cash activity:
Adoption of ASU 2019-12 (Note 2)		$ 13,750

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.